Related Experiment Video
Updated: Aug 25, 2026
Murine Flexor Tendon Injury and Repair Surgery
Published on: September 19, 2016
Inhibition of TGF-beta-induced collagen production in rabbit flexor tendons
Andrew Y Zhang1, Hung Pham, Fred Ho
1Division of Plastic Surgery, Stanford University Medical Center, 770 Welch Road, Stanford, CA 94305, USA.
Purpose:
Postoperative adhesions frequently compromise the success of flexor tendon repair. Manipulation of growth factors responsible for scar formation may be a method of decreasing adhesion formation. Transforming growth factor beta (TGF-beta) is a key cytokine in the pathogenesis of tissue fibrosis. The purpose of this study was to examine the effectiveness of TGF-beta neutralizing antibody in blocking TGF-beta-induced collagen I production in rabbit flexor tendons in vitro.
Methods:
Sheath fibroblasts, epitenon tenocytes, and endotenon tenocytes were obtained from rabbit flexor tendons. Each cell culture was supplemented with 1 ng/mL of TGF-beta along with increasing doses of TGF-beta neutralizing antibody (0.1-2.0 microg/mL). Collagen I production was measured by enzyme-linked immunoabsorbent assay and TGF-beta bioactivity was measured by the luciferase assay. Results were compared with TGF-beta alone and unsupplemented controls.
Results:
The addition of neutralizing antibody significantly reduced TGF-beta-induced collagen I production in a dose-dependent manner in all 3 cell cultures. TGF-beta bioactivity was also reduced by its neutralizing antibody.
Conclusions:
This study shows that TGF-beta inhibition through its neutralizing antibody was effective in cultured flexor tendon cells. The results encourage further experiments that use such agents to modulate flexor tendon wound healing in in vivo models in the hope of eventually blocking the effect of TGF-beta on flexor tendons clinically.
Insights
Transforming growth factor beta (TGF-beta) inhibition effectively reduced collagen production in rabbit flexor tendon cells. This study suggests TGF-beta neutralizing antibodies may help prevent postoperative adhesions in tendon repair.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedic Research
Background:
- Postoperative adhesions are a common complication following flexor tendon repair.
- Transforming growth factor beta (TGF-beta) plays a critical role in scar formation and tissue fibrosis.
- Modulating growth factors like TGF-beta may offer a strategy to reduce adhesion formation.
Purpose of the Study:
- To evaluate the efficacy of a TGF-beta neutralizing antibody in inhibiting TGF-beta-induced collagen I production.
- To investigate the effect of TGF-beta inhibition on different cell types within rabbit flexor tendons.
- To explore potential therapeutic strategies for improving flexor tendon healing.
Main Methods:
- Rabbit flexor tendon cells (sheath fibroblasts, epitenon tenocytes, endotenon tenocytes) were cultured.
- Cells were treated with TGF-beta and varying concentrations of a TGF-beta neutralizing antibody.
- Collagen I production and TGF-beta bioactivity were quantified using ELISA and luciferase assays, respectively.
Main Results:
- The TGF-beta neutralizing antibody significantly decreased TGF-beta-induced collagen I production in all tested cell types.
- This inhibitory effect was dose-dependent.
- TGF-beta bioactivity was also effectively reduced by the neutralizing antibody.
Conclusions:
- TGF-beta inhibition using a neutralizing antibody demonstrated effectiveness in cultured flexor tendon cells.
- These findings support further in vivo investigation of TGF-beta neutralizing agents for modulating tendon wound healing.
- The study holds promise for future clinical applications in preventing flexor tendon adhesions.
